Leo Brady - Concepedia

Author

Leo Brady

University of Bristol

Also Known As

L. Brady, L.R. Brady, Leo Brady

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Bristol University of Łódź Novo Nordisk (Denmark)New York University University of York

About

Leo Brady is an author at University of Bristol specializing in natural sciences, biochemistry, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	5	5	1.7K
2	Biochemistry	5	5	1.7K
3	Medicine	2	2	107
4	Biomolecular Engineering	2	2	358
5	Engineering	1	1	102

Leo Brady

Publications

Citations

H-Index

Page 1

	Year	Citations
A serine protease triad forms the catalytic centre of a triacylglycerol lipase Leo Brady, A.M. Brzozowski, Zygmunt S. Derewenda, Nature Proteinlipid InteractionSerine Protease TriadBiochemistryNatural SciencesMolecular Biology	1990	1.2K
Calcium binding in .alpha.-amylases: an x-ray diffraction study at 2.1-.ANG. resolution of two enzymes from Aspergillus Esper Boel, Leo Brady, A.M. Brzozowski, Biochemistry	1990	317
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins Anne‐Catrin Uhlemann, Angus Cameron, Ursula Eckstein‐Ludwig, Nature Structural & Molecular Biology Bioorganic ChemistryBiochemistryBiochemical TaxonomyNatural SciencesBioanalysis	2005	256
Structure and molecular model refinement of <i>Aspergillus oryzae</i> (TAKA) α-amylase: an application of the simulated-annealing method H. J. Swift, Leo Brady, Zygmunt S. Derewenda, Acta Crystallographica Section B Structural Science Molecular Model RefinementNeutral Alpha-amylaseBiochemistryEngineeringNatural Sciences	1991	102
PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors John W. Liebeschuetz, Stuart Jones, Phillip J. Morgan, Journal of Medicinal Chemistry Drug TargetHit IdentificationBiomolecular Structure PredictionMolecular BiologyLead Identification	2002	85
The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa Stuart Jones, John W. Liebeschuetz, Phillip J. Morgan, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2001	22
NGF receptor TrkAd5: therapeutic agent and drug design target D. Dawbarn, Michael Fahey, Judy J. Watson, Biochemical Society Transactions	2006	13

Page 1